enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Insulin degludec - Wikipedia

   en.wikipedia.org/wiki/Insulin_degludec

   Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba. [7] It is administered via subcutaneous injection to help control the blood sugar level of those with diabetes .

3. Tapering (medicine) - Wikipedia

   en.wikipedia.org/wiki/Tapering_(medicine)

   In medicine, tapering is the practice of gradually reducing the dosage of a medication to reduce or discontinue it. Generally, tapering is done is to avoid or minimize withdrawal symptoms that arise from neurobiological adaptation to the drug.

4. Switching Antidepressants: Safety, Side Effects & Other ... - AOL

   www.aol.com/switching-antidepressants-safety...

   When switching antidepressants, your healthcare provider may recommend switching directly, cross-tapering or tapering down your dosage before you start using your new medication.

5. FDA approves opioid-free pain medication with 'no sign of ...

   www.aol.com/fda-approves-opioid-free-pain...

   A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...

6. FDA approves new type of non-opioid pain medication, 1st of ...

   www.aol.com/fda-approves-type-non-opioid...

   The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx ...

7. Antipsychotic switching - Wikipedia

   en.wikipedia.org/wiki/Antipsychotic_switching

   In general, contraindications to antipsychotic switching are cases in which the risk of switching outweighs the potential benefit. Contraindications to antipsychotic switching include effective treatment of an acute psychotic episode, patients stable on a LAI antipsychotic with a history of poor adherence, and stable patients with a history of self-injurious behavior, violent behavior, or ...

8. FDA approves new pain medication as an alternative to opioids ...

   www.aol.com/fda-approves-pain-medication...

   The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

9. Levacetylleucine - Wikipedia

   en.wikipedia.org/wiki/Levacetylleucine

   Levacetylleucine, sold under the brand name Aqneursa, is a medication used for the treatment of neurological manifestations of Niemann-Pick disease type C. [1] [2] Levacetylleucine is a modified version of the amino acid leucine (N-Acetyl-L-Leucine). [1]